Information For DPL XXXVI
The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

September 16, 2025

Reps. Carter, Harshbarger Introduce 340B ACCESS Act

Reps. Buddy Carter (R-GA) and Diana Harshbarger (R-TN) introduced H.R. 5256, the 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act (340B ACCESS Act). This legislation looks to establish oversight and transparency into the 340B program by updating eligibility requirements and safeguards, creating a neutral 340B data clearinghouse, preventing middlemen and for-profit entities from profiting from the program, and establishing enforceable federal oversight of the program.

Additionally, if the bill is passed, contract pharmacies would be recognized in statute and subject to rules aimed at ensuring covered entities use these arrangements consistent with the intent of the program as specified in the legislation. The legislation would add new requirements for manufacturers, who currently do not have a statutory requirement to ship or facilitate delivery of 340B drugs to contract pharmacies.

[Carter, Harshbarger Introduce Legislation to Ensure Access and Transparency in 340B Drug Pricing Program. Office of Rep. Buddy Carter 10 Sept 2025.]